Singapore-based genomics company Global Gene Corp is partnering with biotech giant Regeneron to build the largest collection of DNA sequenced from people in India.
Why India? The lack of diversity in genomic data is a problem. Most of the worldwide genomic data available to researchers is from people of European heritage. India is home to 1.3 billion people and represents 20 percent of the world’s population, yet less than 1 percent of the world’s genomic data comes from the subcontinent.
The goal: Global Gene Corp didn’t say exactly how many genomes it hopes to sequence over the next few years but said the project will be on the scale of Genomics England, which aims to sequence 100,000 people’s genomes in the UK. The DNA sequences generated from the Indian effort will be paired with people’s medical records to look for genetic links to disease.
Why it matters: Studying Indian genomes could uncover unique genetic risk factors for diseases and explain why some ailments occur more or less often in Indian populations than in Westerners. It could also help identify new or better drugs. “Our view is to drive the same change in health care through genomics that the mobile revolution brought to India,” says Global Gene Corp CEO Sumit Jamuar.
Biotechnology and health
Everything you need to know about artificial wombs
Artificial wombs are nearing human trials. But the goal is to save the littlest preemies, not replace the uterus.
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Some deaf children in China can hear after gene therapy treatment
After deafness treatment, Yiyi can hear her mother and dance to the music. But why is it so noisy at night?
Scientists just drafted an incredibly detailed map of the human brain
A massive suite of papers offers a high-res view of the human and non-human primate brain.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.